The mouse as a model to understand peroxisomal biogenesis and its disorders

Drug Discovery Today: Disease Models

Volumn 1, Issue 3, 2004, Pages 193-198

  Brites, Pedro ^a   Wanders, Ronald J A ^a   Waterham, Hans R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOLEUKODYSTROPHY; BIOGENESIS; BIOLOGICAL MODEL; CELL MIGRATION; CHONDRODYSPLASIA PUNCTATA; COMPARATIVE STUDY; COMPUTER MODEL; DISORDERS OF PEROXISOMAL FUNCTIONS; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LENS; MYELINATION; NERVE CELL; NONHUMAN; OSSIFICATION; PATHOGENESIS; PHENOTYPE; REVIEW; X CHROMOSOME LINKED DISORDER; ZELLWEGER SYNDROME;

EID: 23644444134     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2004.09.003     Document Type: Review

References (35)

1. Depreter, M. et al. (2003) Human peroxisomal disorders. Microsc. Res. Tech. 61, 203-223
2. Wanders, R.J. et al. (1991) Prenatal diagnosis of inborn errors in peroxisomal beta-oxidation. Prenat. Diagn. 11, 253-261
3. Wanders, R.J. (2004) Metabolic and molecular basis of peroxisomal disorders: a review. Am. J. Med. Genet. 126A, 355-375
4. Schutgens, R.B. et al. (1989) Prenatal and perinatal diagnosis of peroxisomal disorders. J. Inherit. Metab. Dis. 12 (Suppl. 1), 118-134
5. McGuinness, M.C. et al. (2001) Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. Mol. Genet. Metab. 74, 256-263
6. Kemp, S. et al. (1998) Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat. Med. 4, 1261-1268
7. Netik, A. et al. (2000) Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice. J. Inherit. Metab. Dis. 23, 615-624
8. Moser, H.W. et al. (1987) The adrenoleukodystrophies. Crit. Rev. Neurobiol. 3, 29-88
9. Gartner, J. et al. (1998) Clinical and genetic aspects of X-linked adrenoleukodystrophy. Neuropediatrics 29, 3-13
10. Aubourg, P. et al. (2000) X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia? Glia 29, 186-190
11. Powers, J.M. et al. (2000) Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J. Neuropathol. Exp. Neurol. 59, 89-102
12. Yamada, T. et al. (2000) Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice. Cell Biochem. Biophys. 32, 239-246
13. Kobayashi, T. et al. (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 232, 631-636
14. Forss-Petter, S. et al. (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J. Neurosci. Res. 50, 829-843
15. Pujol, A. et al. (2002) Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum. Mol. Genet. 11, 499-505
16. Fouquet, F. et al. (1997) Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol. Dis. 3, 271-285
17. Berger, J. et al. (1999) The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression. Eur. J. Biochem. 265, 719-727
18. Gould, S.J. et al. (2000) Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet. 16, 340-345
19. Purdue, P.E. et al. (2001) Peroxisome biogenesis. Annu. Rev. Cell Dev. Biol. 17, 701-752
20. Baes, M. et al. (1997) A mouse model for Zellweger syndrome. Nat. Genet. 17, 49-57
21. Maxwell, M. et al. (2003) Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype. Mol. Cell Biol. 23, 5947-5957
22. Faust, P.L. et al. (1997) Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J. Cell Biol. 139, 1293-1305
23. Faust, P.L. et al. (2001) The peroxisome deficient PEX2 Zellweger mouse: pathologic and biochemical correlates of lipid dysfunction. J. Mol. Neurosci. 16, 289-297
24. Powers, J.M. et al. (1989) Structural and chemical alterations in the cerebral maldevelopment of fetal cerebro-hepato-renal (Zellweger) syndrome. J. Neuropathol. Exp. Neurol. 48, 270-289
25. Faust, P.L. (2003) Abnormal cerebellar histogenesis in PEX2 Zellweger mice reflects multiple neuronal defects induced by peroxisome deficiency. J. Comp. Neurol. 461, 394-413
26. Baumgart, E. et al. (2001) Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am. J. Pathol. 159, 1477-1494
27. White, A.L. et al. (2003) Natural history of rhizomelic chondrodysplasia punctata. Am. J. Med. Genet. 118A, 332-342
28. Motley, A.M. et al. (2002) Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am. J. Hum. Genet. 70, 612-624
29. Ofman, R. et al. (1998) Acyl-CoA:dihydroxyacetonephosphate acyltransferase: cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum. Mol. Genet. 7, 847-853
30. de Vet, E.C. et al. (1998) Alkyl-dihydroxyacetonephosphate synthase. Fate in peroxisome biogenesis disorders and identification of the point mutation underlying a single enzyme deficiency. J. Biol. Chem. 273, 10296-10301
31. Brites, P. et al. (2003) Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata. Hum. Mol. Genet. 12, 2255-2267
32. Rodemer, C. et al. (2003) Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum. Mol. Genet. 12, 1881-1895
33. Baes, M. et al. (2000) Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids. J. Biol. Chem. 275, 16329-16336
34. Fan, C.Y. et al. (1996) Targeted disruption of the peroxisomal fatty acyl-CoA oxidase gene: generation of a mouse model of pseudoneonatal adrenoleukodystrophy. Ann. N.Y. Acad. Sci. 804, 530-541
35. Savolainen, K. et al. (2004) A mouse model for {alpha}-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids. Hum. Mol. Genet. 13, 955-965